Correlation of gene and mediator expression with clinical endpoints in an acute interleukin-1β-driven model of joint pathology

Osteoarthritis and Cartilage

Volumn 17, Issue 6, 2009, Pages 790-797

  Scott, I ^a   Midha, A ^a   Rashid, U ^a,b   Ball, S ^a   Walding, A ^a   Kerry, P ^a   Delaney, S ^a   Cruwys, S ^a  

^a ASTRAZENECA   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Arthritis model; Cartilage; Interleukin 1 (IL 1 ); Joint pathology; Synovitis

Indexed keywords

GLYCOSAMINOGLYCAN; INTERLEUKIN 1BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARTILAGE DEGENERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HYPERALGESIA; INFLAMMATION; JOINT SWELLING; NONHUMAN; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; RAT; SYNOVITIS;

ANIMALS; ANKLE JOINT; ARTHRITIS, EXPERIMENTAL; CARTILAGE, ARTICULAR; FEMALE; GENE EXPRESSION; HUMANS; INJECTIONS, INTRA-ARTICULAR; INTERLEUKIN-1BETA; OSTEOARTHRITIS; RATS; REPRODUCIBILITY OF RESULTS;

EID: 67349236100     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2008.09.016     Document Type: Article

References (33)

1. Harris E.D. The bone and joint decade: a catalyst for progress. Arthritis Rheum 44 (2004) 1969-1970
2. Kean W.F., Kean R., and Buchanan W.W. Osteoarthritis: symptoms, signs and source of pain. Inflammopharmacology 12 (2004) 3-31
3. Felson D.T. An update on the pathogenesis and epidemiology of osteoarthritis. Radiol Clin N Am 42 (2004) 1-9
4. Pelletier J.P., Martel-Pelletier J., and Abramson S.B. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthrits Rheum 44 (2001) 1237-1247
5. Rau H., Frank C., Goretzki G., and Spitz J. Radiosynoviothesis in osteoarthritis and other disorders with concomitant synovitis in comparison to rheumatoid arthritis. Cancer Biother Radiopharm 20 (2005) 349-355
6. Zhang Y., Nevitt M., Niu Y., Lewis C., Torner J., Guermazi A., et al. Reversible MRI features and knee pain fluctuation: the MOST study. Osteoarthr Cartil 15 (2007) S3, C5
7. Wieland H.A., Michaelis M., Kirschbaum J.B., and Rudolphi K.A. Osteoarthritis - an untreatable disease?. Nat Rev Drug Discov 4 (2005) 331-345
8. Rudolphi K., Gerwin N., Verzijl N., van der Kraan P., and van den Berg W. Pralnacasan, an inhibitor of interleukin-1beta converting enzyme, reduces joint damage in two murine models of osteoarthritis. Osteoarthr Cartil 11 (2003) 738-746
9. Zhang X., Mao Z., and Yu C. Suppression of early experimental osteoarthritis by gene transfer of interleukin-1 receptor antagonist and interleukin-10. J Orthop Res. 22 (2004) 742-750
10. Blom A.B., van der Kraan P.M., and van den Berg W.B. Cytokine targeting in osteoarthritis. Curr Drug Targets 8 (2007) 283-292
11. Braddock M., and Quinn A. Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention. Nat Rev Drug Discov 3 (2004) 1-10
12. Iqbal I., and Fleischmann R. Treatment of osteoarthritis with anakinra. Curr Rheumatol Rep 9 (2007) 31-35
13. Loeuille D., Chary-Valckenaere I., Goebel C., Rat A.C., Blum A., Kiefer P., et al. MRI evaluation of the synovial membrane after a single intraarticular injection of anakinra in 7 patients with osteoarthritis of the knee. Arthritis Rheum 9 (2005) S70
14. Brandt K.D. Animal models of osteoarthritis. Biorheology 39 (2002) 221-235
15. Ibrahim S.M., Koczan D., and Thiesen H.J. Gene-expression profile of collagen-induced arthritis. J Autoimmun 18 (2002) 159-167
16. Midha A., Rendall E., Nicol S., and Cruwys S. Characterisation of the intra-articular cytokine profile in streptococcal cell wall-induced arthritis. Rheumatology 42 (2003) 33-38
17. Rioja I., Clayton C.L., Graham S.J., Life P.F., and Dickson M.C. Gene expression profiles in the rat streptococcal cell wall-induced arthritis model identified using microarray analysis. Arthritis Res Ther 7 (2005) R101-R117
18. Thornton S., Sowders D., Aronow B., Witte D.P., Brunner H.I., Giannini E.H., et al. DNA microarray analysis reveals novel gene expression profiles in collagen-induced arthritis. Clin Immunol 105 (2002) 155-168
19. Bakker A.C., Joosten L.A.B., Arntz O.J., Helsen M.M.A., Bendele A.M., van de Loo F.A.J., et al. Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee. Arthritis Rheum 40 (1997) 893-900
20. Caron J.P., Fernandes J.C., Martel-Pelletier J., Tardiff G., Mineau F., Geng C., et al. Chondroprotective effect of intra articular injections of interleukin-1 receptor antagonist in experimental osteoarthritis: suppression of collagenase-1 expression. Arthritis Rheum 39 (1996) 1535-1544
21. Pelletier J.P., Caron J.P., Evans C., Robbins P.D., Georgescu H.I., Jovanovic D., et al. In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. Arthritis Rheum 40 (1997) 1012-1019
22. Schwab J.H., Anderle S.K., Brown R.R., Dalldorf F.G., and Thompson R.C. Pro- and anti-inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats. Infect Immun 59 (1991) 4436-4442
23. Van de Loo F.A.J., Arntz O.J., Otterness I.G., and van den Berg W.B. Protection against cartilage proteoglycan synthesis inhibition by anti-interleukin-1 antibodies in experimental arthritis. J. Rheumatol 19 (1992) 348-356
24. Chandrasekhar S., Harvey A.K., Hrubey P.S., and Bendele A.M. Arthritis induced by interleukin-1 is dependent on the site and frequency of intra-articular injection. Clin Immunol Immunopathol 55 (1990) 382-400
25. Chandrasekhar S., Panetta J.A., and Bendele A.M. Inhibition of IL-1 induced articular inflammation of rats by 4-aminothiazolidines, LY 221068 and LY 269415. Agents Actions 42 (1994) 67-70
26. Henderson B., Thompson R.C., Hardingham T., and Lewthwaite J. Inhibition of interleukin-1 induced synovitis and articular cartilage proteoglycan loss in the rabbit knee by recombinant human interleukin-1 receptor antagonist. Cytokine 3 (1991) 246-249
27. Farndale R.W., Buttle B.J., and Barrett A.J. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochemica et Biophysica Acta 883 (1986) 173-177
28. Dingle J.T., Page-Thomas D.P., King B., and Bard D.R. In vivo studies of articular tissue damage mediated by catabolin/interleukin-1. Ann Rheum Dis 46 (1987) 527-533
29. Pettipher E.R., Higgs G.A., and Henderson B. Interleukin-1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci 83 (1986) 8749-8753
30. Presle N., Cipolletta C., Jouzeau J.Y., Abid A., Netter P., and Terlain B. Cartilage protection by nitric oxide synthase inhibitors after intra-articular injection of interleukin-1β in rats. Arthritis Rheum 42 (1999) 2094-2102
31. Carter R.A., and Wicks I.P. Vascular cell adhesion molecule-1 (CD106): a multifaceted regulator of joint inflammation. Arthritis Rheum 44 (2001) 985-994
32. Haywood L, McWilliams DF, Pearson CI, Gill SE, Ganeasan A, Wilson D, et al. Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum 2003;48:2173-77.
33. Sauer S, Lange BM, Gobom J, Nyarsik L, Seitz H. Miniaturisation in functional genomics and proteomics. Nat Rev Genet 2005;6:465-76.